Author(s):
Uppalapati Vidyamani, Dittakavi Ramachandran, Mannem Durga Babu, Sagi Samba Murthy Raju, Korrapati Uma Maheswar
Email(s):
uvidyamani@gmail.com
DOI:
10.52711/0974-360X.2024.00270 
Address:
Uppalapati Vidyamani1*, Dittakavi Ramachandran2, Mannem Durga Babu3, Sagi Samba Murthy Raju4, Korrapati Uma Maheswar5
1,2Department of Chemistry, Acharya Nagarjuna University, Guntur, Andhra Pradesh, India.
3Department of Chemistry, SVRM College, Nagaram, Guntur, Andhra Pradesh, India.
4Department of Chemistry, KVR, KVR and MKR College, Guntur, Andhra Pradesh, India.
5Department of Chemistry, Bapatla Engineering College, Guntur, Andhra Pradesh, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 4,
Year - 2024
ABSTRACT:
Nitrosamines impurities may be present in low levels in a variety of products that people are exposed to every day. After thorough investigations, regulatory agencies have outlined that the formation of nitrosamines is possible in the presence of secondary, tertiary, or quaternary amines and nitrite salts under acidic reaction conditions. For safety purpose, all API manufacturers must be developed methods to monitor the low levels of each nitrosamine impurity before the release the individual batches. In this article, we have developed novel, rapid and sensitive liquid chromatography Atmospiric pressure chemical ionization Mass spectroscopy (LC-APCI-MS/MS) method for the determination of N-Nitroso Dimethylamine (NDMA), N-Nitroso Diethylamine (NDEA) and N-Nitroso varenicline impurities in the Varenicline Tartrate drug substance and Drug products. Chromatographic separation is achieved using Inert sustain AQ C18 150 × 4.6mm, 3.0µ column with 0.1% formic acid in water as mobile phase A and 0.1% formic acid in methanol as mobile phase B at the 0.6 mL/min flow rate by using gradient mode of elution upto the 25 minutes total run time. The three impurities are successfully ionized and quantified in positive mode of atmospheric pressure chemical ionization (APCI) using multiple reaction monitoring (MRM). This method was validated according to ICH Q2 (R1) guidelines. The method provided excellent S/N ratios with a high linearity range of 0.66-19.88 ppm with respect to Varenicline Tartrate sample concentrations with a regression coefficient >0.995. The recovery for the method was established with a protocol of three-step sample preparation and was satisfactory within 85-115%. The determined LOQ (0.66 ppm) and LOD (0.22 ppm) values are very low with respect to sample concentration which shows the sensitivity Performance of the method. The method can be routinely applied for the detection of N-nitrosamine impurities (NDMA, NDEA and N-Nitroso varenicline) in Varenicline Tartrate drug substance and Drug products.
Cite this article:
Uppalapati Vidyamani, Dittakavi Ramachandran, Mannem Durga Babu, Sagi Samba Murthy Raju, Korrapati Uma Maheswar. Development and Validation of a Rapid and Sensitive LC-APCI-MS/MS Method for the determination of three N-nitrosamine impurities in Varenicline tartrate drug substance and drug products. Research Journal of Pharmacy and Technology.2024; 17(4):1703-0. doi: 10.52711/0974-360X.2024.00270
Cite(Electronic):
Uppalapati Vidyamani, Dittakavi Ramachandran, Mannem Durga Babu, Sagi Samba Murthy Raju, Korrapati Uma Maheswar. Development and Validation of a Rapid and Sensitive LC-APCI-MS/MS Method for the determination of three N-nitrosamine impurities in Varenicline tartrate drug substance and drug products. Research Journal of Pharmacy and Technology.2024; 17(4):1703-0. doi: 10.52711/0974-360X.2024.00270 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-4-44
REFERENCES:
1. ICH M7 Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk. European Medicines Agency, London. https://www.ema.europa.eu/en/ich-m7-assessment-control-dna-reactive-mutagenic-impurities-pharmaceuticals-limit-potential
2. Mirvish, S et al S Formation of N-Nitroso Compounds: Chemistry, Kinetics, and in Vivo Occurrence. Toxicology and Applied Pharmacology. 1975; 31: 325-351.doi.10.1016/0041-008x (75)90255-0
3. Mitch W. A et al. Formation of N-Nitrosodiethylamine (NDMA) from Diethylamine during Chlorination. Environmental Science and Technology. 2002; 36: 588-595. https://doi.org/10.1021/es010684q
4. Genotoxic and Carcinogenic Impurities in Drug Substances and Products. U.S Food and Drug Administration Guidelines for Industry.. Recommended Approaches U.S. Food and Drug Administration, Silver Spring. 2008. https://www.fda.gov>regulatory
5. Chidella K. S et al Ultra-Sensitive LC-MS/MS Method for the Trace Level Quantification of Six Potential Genotoxic Nitrosamine Impurities in Telmisartan. American Journal of Analytical Chemistry. 2021; 12: 227-240. doi:10.4236/ajac.2021.126014
6. Note for Guidance on Pharmaceutical Development. EMEA/CHMP/167068/2004. http://www.emea.europa.eu
7. FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls. U.S. Food and Drug Administration. (Valsartan, Losartan, and Irbesartan). 2019. https://www.fda.gov>drugs
8. Update on Review of Valsartan Medicines Following Detection of Impurity in Active Substance. European Medicines Agency. 2018; EMA 485921. http://www.emea.europa.eu
9. EMA Review of Impurities in Sartan Medicines. European Medicines Agency, London. European Medicines Agency. 2018; EMA 643116. http://www.emea.europa.eu
10. Control of Nitrosamine Impurities in Human Drugs. U.S. Food and Drug Administration. Guidance for Industry. 2021; Silver Spring. https://www.fda.gov
11. Liquid Chromatography-High Resolution Mass Spectrometry (LC-ESI-HRMS) Method for the Determination of Varenicline Nitroso-Drug Substance Related Impurity (NDSRI) in Chantix™ Drug Product and Varenicline Drug Substance. U.S. Food and Drug Administration. 2021. https://www.fda.gov/media/151470/download
12. Tyrvaya- varenicline spray. Daily Med. 2021. https://dailymed.nlm.nih.gov/dailymed
13. Champix EPAR. European Medicines Agency (EMA). Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged. 2021; Retrieved 26 September. http://www.emea.europa.eu
14. "Oyster Point Pharma Announces FDA Approval of Tyrvaya (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease" (Press release). Oyster Point Pharma. 2021. https://investors.oysterpointrx.com
15. U.S. Food and Drug Administration, Silver Spring. Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) Method for the Determination of Six Nitrosamine Impurities in ARB Drugs. 2019. https://www.fda.gov.
16. U.S. Food and Drug Administration, Silver Spring . Liquid Chromatography- Electrospray Ionization-High Resolution Mass Spectrometry (LC-ESIHRMS) Method for the Determination of Nitrosamine Impurities in Metformin Drug Substance and Drug Product. 2020. https://www.fda.gov/media/138617.
17. Chemisches Und Veterinaruntersuchungsamt Karlsruhe. Test Method for the Determination of NDMA by LC/MS/MS in Valsartan Finished Products. 2018. https://www.edqm.eu/sites/default/files/omcl-method-determination-ndma-valsartan-cvua-september2018.pdf.
18. Mannem Durga babu et al Simultaneous determination of 2-chloro methyl propionate, 1,4-di-bromo butane and para anisic aldehyde in Mebeverine hydrochloride API by gas chromatography-mass spectrometric with selected-ion-monitoring mode. Asian J Pharm Clin Res. 2016; 9(2): 168-175. doi: http://dx.doi.org/10.22159/ajpcr.2016.v9s2.13418
19. Mannem Durga babu et al Development and validation of a gas chromatography-mass spectrometry with selected ion monitoring method for the determination of trace levels of methane sulfonyl chloride as an impurity in Itraconazole active pharmaceutical ingredient. Asian J Pharm Clin Res. 2016; 9(5): 403-407. https://journals.innovareacademics.in/index.php/ajpcr/article/view/12823/5879
20. Mannem Durga babu et al Development and validation of a headspace gas Chromatographic method for the determination of Methyl bromide content in Itraconazole API. International Letters of Chemistry, Physics and Astronomy. 2015; 14(59): 160-169. doi:10.18052/www.scipress.com/ILCPA.59.160
21. Gudibanda Chandrasekhar reddy et al Characterization of Loratadine API and Simultaneous Quantification of Seven Potential Genotoxic Nitrosamine Impurities in Single Method by LC-MS/MS in Loratadine API and its Dosage Forms. Asian Journal of Chemistry. 2022. 34: 1505-1512. doi:10.14233/ajchem.2022.23756
22. Gudibanda Chandrasekhar Reddy et al Characterization of Famotidine API and simultaneous Quantification of its organic impurities by UPLC. Research J. Pharm. and Tech. 2023; 16(3): 1421-27. doi: 10.52711/0974-360X.2023.00234
23. Jyoti Dahiya et al. Spectrophotometric Estimation of Dextromethorphan in Bulk Drug using Hydrotropic Solubilization Technique. Asian J. Pharm. Ana. 2013; 3(3): 90-93. https://ajpaonline.com/HTMLPaper.aspx?Journal=Asian%20Journal%20of%20Pharmaceutical%20Analysis;PID=2013-3-3-5
24. N. Usha Rani et al New Spectroscopic Method for Estimation of Atorvastatin Tablets Using Hydrotropic Solubilization Technique. Asian J. Pharm. Ana. 2015; 5(2): 100-104. doi: 10.5958/2231-5675.2015.00016.2
25. Dan Xie et al Method Development and Validation for Simultaneous Determination of 44Ca, 34S, 28Si and 18 Other Trace Elements in Pharmaceutical Packaging Materials’ Extractable Solutions by Inductively Coupled Plasma-Mass Spectrometry (ICP-MS). Asian J. Pharm. Ana. 2020; 10(2): 51-66. doi: 10.5958/2231-5675.2020.00011.3
26. Mohan Goud V et al Stability indicating high performance liquid chromatography method development and validation for simultaneous estimation of Glecaprevir and Pibrentasvir in bulk and pharmaceutical dosage form. Asian J. Pharm. Ana. 2020; 10(3): 141-146. doi: 10.5958/2231-5675.2020.00025.3
27. Mallikarjuna Rao N et al Development and Validation of an Analytical Method for the Estimation of Standard Cholesterol and Egg Cholesterol by High Performance Thin Layer Chromatography (HPTLC). Research J. Pharm. and Tech. 2011; 4(1): 155-159. https://rjptonline.org/HTMLPaper.aspx?Journal=Research%20Journal%20of%20Pharmacy%20and%20Technology;PID=2011-4-1-24
28. S. Hemchand et al. New stability indicating RP-UFLC method for the simultaneous determination of Velpatasvir and Sofosbuvir in tablets. Research J. Pharm. and Tech. 2018; 11(12): 5637-42. doi: 10.5958/0974-360X.2018.01022.3
29. S. Hemchand et al New Validated Stability-Indicating RP-HPLC Method for The Determination of Docetaxel and Its Related Substances. Research J. Pharm. and Tech 2019; 12(9): 4165-81. doi: 10.5958/0974-360X.2019.00719.4
30. S.Hemchand et al Separation, Characterization and quantification of Impurities and Identification of stress degradants of Cabazitaxel by RP-HPLC and LC-ESI-MS techniques. Research J. Pharm. and Tech 2018; 11(10): 4683-98. doi: 10.5958/0974-360X.2018.00857.0
31. S.Hemchand et al Enantiomeric separation and validation of D-isomer in Pemetrexed disodium–An anti-cancer agent using Chiral HPLC. Research J. Pharm. and Tech 2019; 12(2):773-786. doi: 10.5958/0974-360X.2019.00136.7
32. Chandrasekhar Reddy Gudibanda et al Quantification of organic volatile impurities in Oseltamivir phosphate drug substances by head space gas chromatography. Future Journal of Pharmaceutical Sciences.2022; 8(15):1-13.https://doi.org/10.1186/s43094-022-00401-z
33. Mannem Durga babu et al GC-HS method for Organic volatile impurities Determination and Quantification in Setraline HCl API and its Pharmaceutical dosage forms. Asian Journal of Chemistry.2018; 30(8): 1791-95. https://doi.org/10.1186/s43094-022-00401-z
34. C. Ripolles et al Determination of eight nitrosamines in water at the ng L(-1) levels by liquid chromatography coupled to atmospheric pressure chemical ionization tandem mass spectrometry. Anal. Chim. Acta. 2011; 702(1): 62-71. doi: 10.1016/j.aca.2011.06.024
35. Shu-Han Chang et al A multi-analyte LC-MS/MS method for screening and quantification of nitrosamines in sartans. J Food Drug Anal. 2020; 28(2): 292–301. doi: 10.38212/2224-6614.1063
36. W. Wang. Et al Determination of N-nitrosodimethylamine in drinking water by UPLC-MS/MS. J Environ Sci. 2010; 22(10): 1508-12. doi: 10.1016/s1001-0742(09)60281-3
37. Validation of Analytical Procedures Methodology in Proceedings of International Conference on Harmonization, ICH Guidelines, 1996; Q2B; 1-10. https://database.ich.org/sites/default/files/Q2%28R1%29%20Guideline.pdf http://1501-6.doi.org/10.1021/ja061680u